Top Headlines
Welch’s and Blue Marble Biomaterials Announce Collaboration
Welch Foods, Inc. (Concord, MA), a global food and beverage manufacturer, and biochemical manufacturer Blue Marble Biomaterials (Missoula, MT) have announced their intention to collaborate to bring naturally derived biochemicals to the public. The collaboration would enable Blue Marble to expand its manufacturing capacity for natural ingredients (biochemicals) for use in food, fragrance and lifestyle ...
Kemin and OmniActive Place Human Health Above Litigation
On December 5, 2016 OmniActive Health Technologies, Ltd. (Morristown, NJ) and Kemin Industries, Inc. (Des Moines, IA) resolved their legal differences, “placing the importance of human health above litigation,” according to a press release issued by the companies. Both parties will withdraw all legal complaints, cross license each other’s “use patents” and begin to form ...
Lonza to Divest Peptides Business to PolyPeptide
Lonza (Switzerland) and the PolyPeptide Group (Belgium) jointly announced that PolyPeptide Laboratories Holding (PPL) AB has entered into a definitive agreement with Lonza Sales AG and Lonza AG (both 100 percent affiliates of Lonza Group AG) to acquire the peptides business and operations of Lonza in Braine-l’Alleud, Belgium. Lonza’s Braine facility, with approximately 280 employees, ...
Natreon Files Lawsuit Against Ixoreal, Shri Kartikeya Pharma
New Jersey-based Natreon, Inc., supplier of ayurvedic ingredients including Sensoril ashwagandha, filed a lawsuit against Ixoreal Biomed Inc. (California) and its parent company, Shri Kartikeya Pharma, Ltd. (India) on September 30. Natreon’s allegations include unfair competition, trade libel, defamation, and interference with economic relations, among others. An initial filing stated that Ixoreal Biomed’s KSM-66 contained ...
QLaboratories Expands Microbial ID Capabilities
QLaboratories, Inc. (Cincinnati, OH) has added another tool to its microbial identification capabilities by acquiring the Bruker MALDI Biotyper. This technology allows for rapid, cost-effective, accurate identification of thousands of microorganisms (including yeasts and filamentous fungi) using state-of-the-art technology, according to the company. It can be used for environmental, product and/or research and development applications. ...
Ganeden Experts Continue Probiotic Myth-buster Series
While probiotics continue as a top trend, misconceptions and confusion around the category and the benefits of these beneficial bugs linger. That’s why experts from the probiotic ingredient supplier, Ganeden (Mayfield Heights, OH), decided to provide education and awareness on the topic through a unique approach—a myth-buster series called “Probiotics: Beyond the Hype.” Started earlier ...
FTC Issues Statement on Homeopathic Drug Marketing Claims
The Federal Trade Commission (FTC) has announced a new “Enforcement Policy Statement on Marketing Claims for Over-the-Counter (OTC) Homeopathic Drugs.” An FTC workshop held last year to examine how such drugs are marketed to consumers informed the policy statement. The FTC also released its staff report on the workshop, which summarizes the panel presentations and ...
Pharmachem Moves to Measure All “Viable” Cells in Probiotics vs. CFUs
Pharmachem Laboratories, Inc., (Kearny, NJ) announced that it is now using flow cytometry to more accurately and quickly measure the viable cells in probiotic formulas as opposed to the traditional plating method which measures only colony forming units (CFUs). According to Alexis Collins, director of scientific affairs for Pharmachem, at least one-third of the company’s ...
AHPA Submits Vinpocetine Comments to FDA
The American Herbal Products Association (AHPA) recommends the Secretary of Health and Human Services (HHS) consider initiating rulemaking to declare vinpocetine to be lawful dietary ingredient in comments submitted to the U.S. Food and Drug Administration (FDA). AHPA also strongly encouraged FDA to clarify that if vinpocetine is either found to be currently in the ...
Seipel Group Receives U.S. Patent on Urox
The Seipel Group Pty Ltd., an Australian company committed to the research and development of specialized formulations to improve bladder control, has been granted U.S. Patent No. 9,452,191 for Herbal compositions for the prevention or treatment of urinary incontinence and overactive bladder. Seipel Group has registered the U.S. trademark Urox for the formula, a proprietary ...
Don't Miss Out!
Industry Professionals
Stay Informed!
Stay informed about the latest health, nutrition, and wellness developments by signing up for a FREE subscription to Nutrition Industry Executive magazine and digital newsletter.
Once subscribed, you will receive industry insights, product trends, and important news directly to your doorstep and inbox.
Featured Listings:
